CLINICAL_TRIALS
trial_result
· 2025-11-03
Clinical Trial Update: Clinical Trial Evaluating ITI-007 (Lumateperone) as a Monotherapy for the Treatment of Bipolar Depression [Phase 3]
Summary
Phase 3 trial evaluating ITI-007 (lumateperone) as monotherapy for bipolar depression has completed and results have been posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Intra-Cellular Therapies, Inc. | Conditions: Bipolar Depression | Phase 3 | Status: COMPLETED | Results posted: 2025-11-03